Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.

<h4>Background</h4>Few studies have examined outcomes for children treated for multidrug-resistant tuberculosis (MDR-TB), including those receiving concomitant treatment for MDR-TB and HIV co-infection. In Lesotho, where the adult HIV seroprevalence is estimated to be 24%, we sought to m...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hind Satti, Megan M McLaughlin, David B Omotayo, Salmaan Keshavjee, Mercedes C Becerra, Joia S Mukherjee, Kwonjune J Seung
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2012
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/4ecce01310cf4e1ebb4c3405d6d985b9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4ecce01310cf4e1ebb4c3405d6d985b9
record_format	dspace
spelling	oai:doaj.org-article:4ecce01310cf4e1ebb4c3405d6d985b92021-11-18T07:17:51ZOutcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.1932-620310.1371/journal.pone.0037114https://doaj.org/article/4ecce01310cf4e1ebb4c3405d6d985b92012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22629356/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Few studies have examined outcomes for children treated for multidrug-resistant tuberculosis (MDR-TB), including those receiving concomitant treatment for MDR-TB and HIV co-infection. In Lesotho, where the adult HIV seroprevalence is estimated to be 24%, we sought to measure outcomes and adverse events in a cohort of children treated for MDR-TB using a community-based treatment delivery model.<h4>Methods</h4>We reviewed retrospectively the clinical charts of children ≤15 years of age treated for culture-confirmed or suspected MDR-TB between July 2007 and January 2011.<h4>Results</h4>Nineteen children, ages two to 15, received treatment. At baseline, 74% of patients were co-infected with HIV, 63% were malnourished, 84% had severe radiographic findings, and 21% had extrapulmonary disease. Five (26%) children had culture-confirmed MDR-TB, ten (53%) did not have culture results available, and four (21%) subsequently had results indicating drug-susceptible TB. All children with HIV co-infection who were not already on antiretroviral therapy (ART) were initiated on ART a median of two weeks after the start of the MDR-TB regimen. Among the 17 patients with final outcomes, 15 (88%) patients were cured or completed treatment, two (12%) patients died, and none defaulted or were lost to follow-up. The majority of patients (95%) experienced adverse events; only two required permanent discontinuation of the offending agent, and only one required suspension of MDR-TB treatment for more than one week.<h4>Conclusions</h4>Pediatric MDR-TB and MDR-TB/HIV co-infection can be successfully treated using a combination of social support, close monitoring by community health workers and clinicians, and inpatient care when needed. In this cohort, adverse events were well tolerated and treatment outcomes were comparable to those reported in children with drug-susceptible TB and no HIV infection.Hind SattiMegan M McLaughlinDavid B OmotayoSalmaan KeshavjeeMercedes C BecerraJoia S MukherjeeKwonjune J SeungPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 5, p e37114 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Hind Satti Megan M McLaughlin David B Omotayo Salmaan Keshavjee Mercedes C Becerra Joia S Mukherjee Kwonjune J Seung Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
description	<h4>Background</h4>Few studies have examined outcomes for children treated for multidrug-resistant tuberculosis (MDR-TB), including those receiving concomitant treatment for MDR-TB and HIV co-infection. In Lesotho, where the adult HIV seroprevalence is estimated to be 24%, we sought to measure outcomes and adverse events in a cohort of children treated for MDR-TB using a community-based treatment delivery model.<h4>Methods</h4>We reviewed retrospectively the clinical charts of children ≤15 years of age treated for culture-confirmed or suspected MDR-TB between July 2007 and January 2011.<h4>Results</h4>Nineteen children, ages two to 15, received treatment. At baseline, 74% of patients were co-infected with HIV, 63% were malnourished, 84% had severe radiographic findings, and 21% had extrapulmonary disease. Five (26%) children had culture-confirmed MDR-TB, ten (53%) did not have culture results available, and four (21%) subsequently had results indicating drug-susceptible TB. All children with HIV co-infection who were not already on antiretroviral therapy (ART) were initiated on ART a median of two weeks after the start of the MDR-TB regimen. Among the 17 patients with final outcomes, 15 (88%) patients were cured or completed treatment, two (12%) patients died, and none defaulted or were lost to follow-up. The majority of patients (95%) experienced adverse events; only two required permanent discontinuation of the offending agent, and only one required suspension of MDR-TB treatment for more than one week.<h4>Conclusions</h4>Pediatric MDR-TB and MDR-TB/HIV co-infection can be successfully treated using a combination of social support, close monitoring by community health workers and clinicians, and inpatient care when needed. In this cohort, adverse events were well tolerated and treatment outcomes were comparable to those reported in children with drug-susceptible TB and no HIV infection.
format	article
author	Hind Satti Megan M McLaughlin David B Omotayo Salmaan Keshavjee Mercedes C Becerra Joia S Mukherjee Kwonjune J Seung
author_facet	Hind Satti Megan M McLaughlin David B Omotayo Salmaan Keshavjee Mercedes C Becerra Joia S Mukherjee Kwonjune J Seung
author_sort	Hind Satti
title	Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
title_short	Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
title_full	Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
title_fullStr	Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
title_full_unstemmed	Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
title_sort	outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high hiv prevalence.
publisher	Public Library of Science (PLoS)
publishDate	2012
url	https://doaj.org/article/4ecce01310cf4e1ebb4c3405d6d985b9
work_keys_str_mv	AT hindsatti outcomesofcomprehensivecareforchildrenempiricallytreatedformultidrugresistanttuberculosisinasettingofhighhivprevalence AT meganmmclaughlin outcomesofcomprehensivecareforchildrenempiricallytreatedformultidrugresistanttuberculosisinasettingofhighhivprevalence AT davidbomotayo outcomesofcomprehensivecareforchildrenempiricallytreatedformultidrugresistanttuberculosisinasettingofhighhivprevalence AT salmaankeshavjee outcomesofcomprehensivecareforchildrenempiricallytreatedformultidrugresistanttuberculosisinasettingofhighhivprevalence AT mercedescbecerra outcomesofcomprehensivecareforchildrenempiricallytreatedformultidrugresistanttuberculosisinasettingofhighhivprevalence AT joiasmukherjee outcomesofcomprehensivecareforchildrenempiricallytreatedformultidrugresistanttuberculosisinasettingofhighhivprevalence AT kwonjunejseung outcomesofcomprehensivecareforchildrenempiricallytreatedformultidrugresistanttuberculosisinasettingofhighhivprevalence
_version_	1718423662309146624

Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.

Ejemplares similares